Vimovo Lawsuit
Update: Study Finds Increased Risk of Death with PPI Heartburn Medications July 5, 2017 – Proton pump inhibitors have been linked to a 25% greater risk of death compared to patients who took H2 blockers, according to a study published Monday in BMJ. The study also found that PPI use was linked to a 15% […]
What is Farxiga? Farxiga (generic: dapagliflozin) is a sodium-glucose co-transporter 2 (SGLT2) inhibitor used to control blood sugar levels in adults with type 2 diabetes. The drug works by blocking the action of the SGLT2 protein, preventing the kidneys from reabsorbing glucose back into the bloodstream. Farxiga is made by AstraZeneca, and was approved by […]
Update: Farxiga Litigation Centralized in New York April 13, 2017 – The U.S. Judicial Panel on Multidistrict Litigation (JPML) has ordered that all federal lawsuits involving Farxiga and Xigduo XR be centralized for pretrial handling in the Southern District of New York. JPML agreed that the actions share factual questions arising from the allegations, thus […]
Get Help Now Prescription Drug Journal is sponsored by Schmidt & Clark, LLP. The law firm firm is recognized as “One of The Nation’s Leading Law Firms” and has been helping America’s injured individuals and families since 1992. Schmidt & Clark, LLP is handling Farxiga cases nationwide and you can contact them below. To learn […]
What is Protonix? Protonix (generic: pantoprazole) is a proton pump inhibitor (PPI) medication that decreases the amount of acid produced in the stomach. The drug is used to to treat gastroesophageal reflux disease (GERD) and other conditions involving excess stomach acid such as Zollinger-Ellison syndrome. Protonix is made by Pfizer Inc., and was first approved […]
Update: Study Finds Increased Risk of Death with PPI Heartburn Medications July 5, 2017 – Proton pump inhibitors have been linked to a 25% greater risk of death compared to patients who took H2 blockers, according to a study published Monday in BMJ. The study also found that PPI use was linked to a 15% […]
Get Help Now Prescription Drug Journal is sponsored by Schmidt & Clark, LLP. The law firm firm is recognized as “One of The Nation’s Leading Law Firms” and has been helping America’s injured individuals and families since 1992. Schmidt & Clark, LLP is handling Protonix cases nationwide and you can contact them below. To learn […]
What is Invokamet? Invokamet contains canagliflozin and metformin, oral diabetes medications that help control blood sugar levels in patients with type 2 diabetes. Canagliflozin works by helping the kidneys expel glucose from the blood through the urine. Invokamet is made by Janssen Pharmaceuticals (a Johnson & Johnson company), and was approved by the U.S. Food […]
Get Help Now Prescription Drug Journal is sponsored by Schmidt & Clark, LLP. The law firm firm is recognized as “One of The Nation’s Leading Law Firms” and has been helping America’s injured individuals and families since 1992. Schmidt & Clark, LLP is handling Invokamet cases nationwide and you can contact them below. To learn […]
Update: FDA Requires Boxed Warning on Amputation Risk with Invokana May 16, 2017 – Based on the final results of 2 long-term clinical trials, FDA has concluded that type 2 diabetes patients who take Invokana or Invokamet are twice as likely to have their foot or toe amputated. As a result of these findings, the […]